Becton Dickinson beat expectations for first-quarter results and said its board has authorized a plan to separate its biosciences and diagnostic solutions unit on Wednesday, as the medical device ...
American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...
In keeping with the trend in med tech to return to basics, Becton, Dickinson and Co. plans to split off its biosciences and diagnostic solutions unit to create two pure-play companies. The ‘New BD’ or ...
Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...
Systemic Bioâ„¢, a 3D Systems company (NYSE: DDD), has been named the winner of the prestigious SLAS 2025 Innovation Award. This award recognizes groundbreaking technological advancements poised to ...